Phase I/II Study of Mezigdomide and Elranatamab for Relapsed/refractory Multiple Myeloma Patients
Latest Information Update: 28 Oct 2024
At a glance
- Drugs Elranatamab (Primary) ; Mezigdomide (Primary) ; Dexamethasone; Diphenhydramine; Paracetamol
- Indications Multiple myeloma
- Focus Therapeutic Use
- 23 Oct 2024 New trial record